ask="1.890"
ask_size="6000"
average_daily_volume="721653"
bid="1.500"
bid_size="500"
book_value="1.067"
change="-0.031"
change_from_200_day_moving_average="-0.363"
change_from_50_day_moving_average="0.124"
change_from_52_week_high="-4.113"
change_From_52_week_low="1.645"
change_in_percent="-1.839%"
close="1.655"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.006"
ebitda="-16.58M"
eps_estimate_current_year="-2.910"
eps_estimate_next_quarter="-0.060"
eps_estimate_next_year="-1.370"
ex_dividend_date="N/A"
float_shares="5773000"
high="1.730"
high_52_weeks="5.768"
last_trade_date="2/16/2017"
last_trade_price="1.655"
last_trade_size="345"
last_trade_time="3:59pm"
low="1.630"
low_52_weeks="0.010"
market_capitalization="19.35M"
moving_average_200_day="2.018"
moving_average_50_day="1.531"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.000"
open="1.690"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-17.992%"
percent_change_from_50_day_moving_average="+8.129%"
percent_change_from_52_week_high="-71.307%"
percent_change_from_52_week_low="+15661.904%"
previous_close="1.686"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.580"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.210"
stock_exchange="NCM"
symbol="PZRX"
volume="34435"
weeks_range_52="0.010 - 5.768"
